SCHEMBL12769332

SCHEMBL12769332

COc1ccc(CO[C@H](/C(F)=C\[C@@H](C)C(C)O[Si](C)(C)C(C)(C)C)[C@H]2OC(C)(C)O[C@H]2CC=O)cc1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13155308 1.00 APLNR (0.31) APLNR
SCHEMBL12772284 0.92 — —
SCHEMBL13155301 0.92 — —
SCHEMBL12769305 0.92 — —
SCHEMBL13155310 0.89 — —
SCHEMBL12769333 0.89 — —
SCHEMBL12772329 0.89 — —
SCHEMBL18570692 0.86 GLA (0.31) —
SCHEMBL12772321 0.86 MAPT (0.30) —
SCHEMBL12769334 0.86 MAPT (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915306-B2 For therapy of inflammatory or autoimmune disorders EISAI CO., LTD. (JP) 2011-03-29 — — US disclosed
US-7799827-B2 Macrocyclic compounds useful as pharmaceuticals EISAI CO., LTD. (JP) 2010-09-21 — — US disclosed
Send feedback